Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/dfe56e32-81f8-4afe-ad4b-c7fd114234a5/
TLX
Telix Pharmaceuticals LimitedSnapshot 2026-07-19 · 0.7w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
1.0%ile
P/S
6.3×
P/B
12.2×
E/P
0.0034
FCF Yield
-0.011
EBITDA/EV
0.007
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
98.00000000
/100 — 1=cheapest
VC2 (Trending Value)
98.00000000
/100
VC3 (Buyback)
98.00000000
/100
Negative FCF yield (-1.1%) — the business is currently cash-consumptive. VC2 score of 98.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
6.0%ile
ROE
-0.017
ROA
-0.006
Net Margin
-0.009
Op Margin
0.022
GPA
0.366
Current
1.43
F-Score
2/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.556
5yr Consist
No
F-Score of 2/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
4.0%ile
6M Return
29.9%
12M Return
-41.0%
12-1 Mom
-42.6%
Risk-Adj
-0.79
Vol 252d
53.8%
Vol 60d
115.9%
↑ Expanding
Max DD 12M
-58.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -43% signals a downtrend — price is moving against you. Near-term vol (116%) is expanding vs long-term (54%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.0
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
4.1%
Sector Quality %ile
11.6%
P/B z-score
0.37
Sector Avg OS
45.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (116%) significantly exceeds 252-day (54%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
13.6% avg (6 factors)
Quality
F
24.1% avg (6 factors)
Momentum
F
20.0% avg (4 factors)
Risk
F
27.1% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.000 | —7 | — | |
| Value %ile | 0.010 | —7 | — | |
| Quality %ile | 0.060 | —7 | — | |
| Momentum %ile | 0.040 | —7 | — | |
| F-Score | 2.000 | —7 | — | |
| Confidence | 0.653 | —0 | — | |
| Volatility | 0.538 | —7 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Earnings Yield (E/P)
0.0034
Price / Sales
6.28
Price / Book
12.16
FCF Yield
-1.1%
EBITDA / EV
0.7%
Sales Yield (1/P·S)
0.1495
Shareholder Yield
Div + net buyback / mktcap
-0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-1.7%
Return on Assets
-0.6%
Net Margin
-0.9%
Operating Margin
2.2%
Gross Profit / Assets
Novy-Marx GPA
36.6%
Current Ratio
1.43
MomentumPrice trend strength over different horizons
6M Return
29.9%
12M Return
-41.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-42.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.79
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
55.6%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
2
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
98
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
98
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
98
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity